| 2433 |
Decrease, Telomere attrition
Short Name
Telomere attrition
|
0 |
Molecular |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2434 |
Disruption, Mitochondrial dysfunction
Short Name
Mitochondrial dysfunction
|
0 |
Cellular |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2435 |
Increase, Myocardial and vascular structural remodeling
Short Name
Myocardial and vascular structural remodeling
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2436 |
Increase, Systemic inflammation
Short Name
Systemic inflammation
|
0 |
Cellular |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2437 |
Increase, Blood pressure elevation
Short Name
Blood pressure elevation
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2438 |
Increase, Cardiovascular aging
Short Name
Cardiovascular aging
|
0 |
Individual |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2439 |
Increase, Telomere attrition
Short Name
Increase, Telomere attrition
|
0 |
Molecular |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2440 |
Increase, Hepatic inflammation
Short Name
Hepatic inflammation
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2441 |
Increased , Fatty acid synthesis and transport
Short Name
Increased fatty acid synthesis and transport
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
|
| 2442 |
Increase, Abnormal lipid accumulation
Short Name
Abnormal lipid accumulation
|
0 |
Organ |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2443 |
Increase, Hepatocyte injury
Short Name
Hepatocyte injury
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2444 |
Increase, Progesterone resistance
Short Name
Progesterone resistance
|
0 |
Cellular |
Jul 17, 2026 |
Jul 17, 2026 |
577: AhR activation leading to endometriosis
|
| 2445 |
Increase, Blood pressure
Short Name
Blood pressure
|
0 |
Organ |
Jul 24, 2026 |
Jul 24, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2446 |
Increase, lipid accumulation
Short Name
lipid accumulation
|
0 |
Tissue |
Jul 24, 2026 |
Jul 24, 2026 |
646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
|
| 2447 |
Increase, Keap1 cysteine modification
Short Name
Keap1 cysteine modification
|
0 |
Molecular |
Aug 12, 2026 |
Aug 12, 2026 |
None
|
| 2448 |
Brain insulin-degrading enzyme (IDE), inhibition
Short Name
IDE inhibition
|
0 |
Molecular |
Aug 31, 2026 |
Aug 31, 2026 |
652: Inhibition of brain insulin-degrading enzyme (IDE) leads to cognitive decline (adult)
|
| 2449 |
Brain amyloid-beta (Aβ) accumulation, increased
Short Name
Abeta accumulation
|
0 |
Cellular |
Aug 31, 2026 |
Aug 31, 2026 |
652: Inhibition of brain insulin-degrading enzyme (IDE) leads to cognitive decline (adult)
|
| 2450 |
Cognitive Decline (Adult)
Short Name
Cognitive Decline (Adult)
|
0 |
Individual |
Aug 31, 2026 |
Aug 31, 2026 |
652: Inhibition of brain insulin-degrading enzyme (IDE) leads to cognitive decline (adult)
|
| 2451 |
Increase, TDP-43 aggregation
Short Name
TDP-43 aggregation
|
0 |
Cellular |
Sep 6, 2026 |
Sep 6, 2026 |
636: Increase in reactive oxygen species (ROS) leading to human amyotrophic lateral sclerosis (ALS)
|